Vaishali Pharma Limited
NSE:VAISHALI.NS
192.25 (INR) • At close September 19, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Vaishali Pharma Limited |
Symbool | VAISHALI.NS |
Munteenheid | INR |
Prijs | 192.25 |
Beurswaarde | 2,060,766,200 |
Dividendpercentage | 0% |
52-weken bereik | 118.15 - 212 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Atul Arvind Vasani |
Website | https://www.vaishalipharma.com |
An error occurred while fetching data.
Over Vaishali Pharma Limited
Vaishali Pharma Limited engages in the pharmaceutical business in India and internationally. It offers active pharmaceutical ingredients (APIs), including antibiotics, anti-ulcer, anti-inflammatory/analgesic/anti-pyretic, anti-malarial, cardiac, anti-diabetic, anti-cold/anti-allergic, anti-diarrheal/anti-protozoal/anti-parasitic, anti-viral, anti-epileptic, anti-asthmatic, anti-fungal, anti-platelet agent, skeletal muscle relaxant, and anti-helmintic drugs, as well as excipients, topical steroids, corticosteroids, and enzymes. The company
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (INR)
Cijfers zijn in miljoenen (INR)